Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra ...

As few as one in ten people survive pancreatic cancer five years after their diagnosis — making it the most difficult cancer to survive. The survival rate five years after diagnosis is 6-14%, but ...

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Cancer remains a leading cause of death globally but according to the World Health Organisation many cancers can be beaten if ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...

日前，纪念斯隆凯特琳癌症中心（MSKCC）科学家领衔的研究团队，在《自然》期刊上发表了由BioNTech和罗氏（Roche）联合开发的个体化新抗原疫苗autogene ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...